Private Equity Investment into IVF

Examining private equity’s role in fertility care

2:30 PM

View Transcript

In a recent paper published in JAMA, researchers find that over 50% of IVF cycles in the United States are now done at fertility clinics affiliated with private equity firms. Read the full article here.

Transcript

Host: 

Welcome to Health Lab, your destination for news and stories about the future of healthcare. 

Today: We’re looking at when private equity invests in IVF, and examining private equity’s role in fertility care.

Researchers find over 50% of IVF cycles are now done at fertility clinics affiliated with private equity firms.

Over the past decade, the rise of private equity firms investing in health care facilities across the United States has been exploding, and because of that rapid growth, researchers have begun digging into what this could mean for health care and patients in the long term. 

In recent years, private equity firms have become much more active in the fertility space, where many patients seek care for reproductive issues and pursue in vitro fertilization, or IVF, which costs thousands of dollars, and usually isn’t covered by insurance.

James Dupree, M.D., M.P.H., and his colleagues wanted to explore what these changes could mean for patients with infertility. 

Dr. Dupree is a professor of urology and obstetrics and gynecology at the University of Michigan Medical School, who directs U-M Health’s Male Fertility Preservation Program and studies fertility care.

In their recent paper, published in JAMA, the team shows that since 2013, expansive growth has been seen in affiliations between fertility clinics and private equity firms. 

They also find that over half of the IVF cycles in the country in 2023 were done at clinics affiliated with private equity firms. 

Further examination of the links between IVF clinics and private equity show that a federal law requires every fertility clinic to report data about their IVF cycles to the federal Centers for Disease Control and Prevention. 

The team used those reports from 2013 to 2022 to examine every IVF clinic in the country, which includes private practices and hospital-based clinics, and they used other databases and online searches to identify which clinics were affiliated with private equity firms. 

What they found was exponential, dramatic growth. To put it in context, in 2013, only 4% of fertility clinics in the United States were affiliated with private equity firms. But since then, the number has grown to be eight times as big.

“As of 2023, we estimate that 32% of IVF clinics were affiliated with private equity firms,” explains Dupree. He goes on, “And these clinics affiliated with these private equity firms are performing over half of the IVF cycles in the country.”

So what does that mean?

Dr. Dupree says, “There’s a lot we don’t know yet. It might be good for patients; it costs a lot of money to modernize IVF laboratory equipment and perform outreach to patients and private equity firms can provide capital to hopefully improve quality and patient care.”

He also explains that in other health care settings outside fertility care, there is data to suggest quality could decline while costs increase.

“We don’t know yet in the fertility world whether this is a net gain for patients or net loss,” he said. 

Dr. Dupree emphasizes how private equity-supported fertility care will be a crucial business model to continue examining, especially with the government’s recent interest in making IVF care more accessible to Americans with infertility.

He said, “Given how prevalent the business model is, we need to do more research and understand the benefits and risks — like the quality of care, cost of care, access to care — are they better or are they worse?”

As a top researcher in the area, Dr. Dupree and his team will continue his work looking into fertility care across the United States, including how IVF is covered by insurance companies, to help hopefully inform future health policies and help patients in the long run. 

A reminder that all Health Lab content including health news, best practices and research insights are for informational purposes only, and are not a substitute for professional medical guidance. Always seek the advice of a health care provider for questions about your health and treatment options.

For more on this story and for others like it, visit michiganmedicine.org/health-lab where you can also subscribe to our Health Lab newsletters to receive the latest in health, wellness and medical research information to your inbox each week. Health Lab is a part of the Michigan Medicine Podcast Network, and is produced by the Michigan Medicine Department of Communication. You can subscribe to Health Lab wherever you listen to podcasts.


More Articles About:

fertility Healthcare Medical School Michigan Medicine equity podcast
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells

Health Lab Podcast

Listen to more Health Lab podcasts - a part of the Michigan Medicine Podcast Network.

Featured News & Stories

women looking at model hand in front of poster and computer on table next to them
Health Lab

Rethinking how clinicians learn to feel disease

For most doctors, learning to recognize swollen joints begins in the classroom. A clinical assistant professor in Michigan Medicine's Division of Rheumatology saw a gap in how to distinguish subtle swelling in joints, thus creating a hand simulator to help.
Portrait of Thomas Macek. He's wearing a navy blazer and light blue button-down shirt.
Philanthropy News

College of Pharmacy alum advances U-M Medical School addiction research

Grateful for support that help launched his career in pharmacology research and drug development, Tom Macek, Ph.D., has made a gift to the University of Michigan Medical School to advance addiction research.
Well-Being at Michigan Medicine with Dr. Elizabeth Harry
Well-Being at Michigan Medicine

Rethinking care: How ‘de-implementation’ can improve quality and reduce burnout

In this episode of Well-Being at Michigan Medicine with Dr. Elizabeth Harry, Dr. Eve Kerr explores the concept of de-implementation—scaling back unnecessary tests, treatments, and administrative hurdles. Kerr shares how eliminating low-value practices can reduce clinician overload, lower patient costs, and improve overall health outcomes. Discover how both healthcare organizations and local frontline teams can foster a culture of high-value care by eliminating outdated processes.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals

The Questions That Shape the Future of Medicine

On this episode of The Fundamentals, we talked to Dr. Thomas J. Wang, dean of the University of Michigan Medical School, about the fundamental questions that have shaped his career and continue to drive biomedical research. Dean Wang discusses his work in cardiovascular research, the enduring impact of the Framingham Heart Study, the potential of AI and emerging health data, and the importance of collaboration between academia and industry. He also shares advice for the next generation of scientists and physicians and explains why sustained investment in biomedical research is essential to improving human health.
presentation on stage with slideshow up
Health Lab

Medical students develop novel technological solutions for unmet patient needs

University of Michigan medical students showcased AI-driven healthcare innovation projects focused on melanoma support, transplant recovery and primary care access.
egg freezing in lab
Health Lab

Egg freezing: What women should know about fertility preservation

An egg-freezing question and answer article with two Michigan Medicine experts.